Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unraveling the care pathway for CAR T-cell therapy in large B-cell lymphoma: insights from a nationwide study in France (2018-2023).

Leukemia & lymphoma·2026
Same author

Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

ESMO open·2025
Same author

One-Day Brentuximab-Bendamustine (120 mg/m2) Every 21 Days is a Feasible, Safe and Effective Treatment for Relapsed/Refractory Hodgkin Lymphoma.

Hematological oncology·2024
Same author

Trichophyton mentagrophytes ITS genotype VII infections among men who have sex with men in France: An ongoing phenomenon.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Real-world data for marginal zone lymphoma patients in the French REALYSA cohort: The REALMA study.

Hematological oncology·2024

Related Experiment Video

Updated: Mar 15, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

14.0K

[Radiotherapy for localized gastric and orbital MALT lymphomas].

L Quéro1, C Hennequin1, S Amorim2

  • 1Service de cancérologie-radiothérapie, hôpital Saint-Louis, AP-HP, 1, avenue Claude-Vellefaux, 75010 Paris, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|September 12, 2016
PubMed
Summary

Radiotherapy is an effective treatment for localized gastric and orbital MALT lymphomas. This approach is well-tolerated, offering a good prognosis for patients, especially when Helicobacter pylori infection is absent or successfully treated.

Keywords:
GastricGastriqueLymphomaLymphomeMALTNon hodgkinienNon-HodgkinOrbitaireOrbitaryRadiotherapyRadiothérapieReviewRevue

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

348

Related Experiment Videos

Last Updated: Mar 15, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

14.0K
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K
Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer
05:30

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

348

Area of Science:

  • Oncology
  • Hematology
  • Gastroenterology

Background:

  • Primary gastric and orbital MALT lymphomas are indolent B-cell non-Hodgkin's lymphomas.
  • These tumors are traditionally radiosensitive with a favorable prognosis.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of radiotherapy for localized MALT lymphomas.
  • To assess radiotherapy as a treatment option in specific clinical scenarios involving MALT lymphomas.

Main Methods:

  • Review of retrospective studies on radiotherapy for MALT lymphomas.
  • Analysis of treatment outcomes in localized orbital and gastric MALT lymphomas.

Main Results:

  • Radiotherapy demonstrated effectiveness in treating localized MALT lymphomas.
  • The treatment was found to be well-tolerated by patients.
  • Efficacy was noted in cases without H. pylori or with persistent infection post-eradication.

Conclusions:

  • Radiotherapy is a viable and effective treatment for localized gastric and orbital MALT lymphomas.
  • It offers a good prognosis and is well-tolerated, particularly in specific patient groups.